Testing effectiveness (Phase 2)Looking for participantsNCT06509984
What this trial is testing
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
Who this might be right for
Epidermolysis Bullosa SimplexGenodermatosis
Centre Hospitalier Universitaire de Nice 20